Paper37875
Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.
El-Mehairy MM and 4 others. Br J Clin Pharmacol, 1979. Cited by 12 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined. Papers, record 37875. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37875
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic beta-Antagonists | Major topic |
| Hydrochlorothiazide | Major topic |
| Hypertension | Major topic |
| Propanolamines | Major topic |
| Aged | |
| Blood Pressure | |
| Drug Evaluation | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14,022,747 | The vascular effect of the thiazide diuretics. | Arch Intern Med | 1963 | https://conductscience.org/library/papers/14022747 | PubMed |
| 2 | 16,040 | Metabolic studies in patients with nadolol: oral and intravenous administration. | J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/16040 | PubMed |
| 3 | 23,284 | Antihypertensive drugs: clinical pharmacology and therapeutic use. | Drugs | 1977 | https://conductscience.org/library/papers/23284 | PubMed |
| 4 | 241,655 | Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. | Eur J Pharmacol | 1975 | https://conductscience.org/library/papers/241655 | PubMed |
| 5 | 4,105,752 | Twice-daily propranolol treatment for hypertension. | Lancet | 1971 | https://conductscience.org/library/papers/4105752 | PubMed |
| 6 | 4,390,767 | Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. | Clin Pharmacol Ther | 1969 | https://conductscience.org/library/papers/4390767 | PubMed |
| 7 | 5,084,985 | Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. | N Engl J Med | 1972 | https://conductscience.org/library/papers/5084985 | PubMed |
| 8 | 5,149,097 | Treatment of hypertension with propranolol and hydralazine. | Acta Med Scand | 1971 | https://conductscience.org/library/papers/5149097 | PubMed |
| 9 | 5,640,884 | Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. | Circulation | 1968 | https://conductscience.org/library/papers/5640884 | PubMed |
| 10 | 579,417 | Hypertension and angina pectoris: pathophysiology and treatment. | JAMA | 1978 | https://conductscience.org/library/papers/579417 | PubMed |
| 11 | 74,494 | Coronary heart-disease after treatment of hypertension. | Lancet | 1978 | https://conductscience.org/library/papers/74494 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,884,417 | Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6884417 | PubMed |
| 6,105,067 | Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. | Drugs | 1980 | https://conductscience.org/library/papers/6105067 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37875
GET https://conductscience.org/api/papers/v1/37875/authors